logo
Dad speaks out after 4-year-old daughter gets serious complications from flu

Dad speaks out after 4-year-old daughter gets serious complications from flu

Yahoo07-03-2025

An Ohio father is speaking out after his 4-year-old daughter developed severe complications from the flu, including a severe brain injury.
"I just want people to take the flu more seriously," Bradley Boler, a security guard and father of four in Chillicothe, Ohio, told "Good Morning America."
"I'm just an average guy working your 9 to 5, trying to take care of my kids and my family. I always thought that the flu was just, take some medicine, rest and you're OK … and it struck down Locklynn."
According to the Centers for Disease Control and Prevention, the flu, or influenza, is a "contagious respiratory illness caused by influenza viruses" that can be mild to severe and is spread through "tiny droplets made when people with flu cough, sneeze, or talk."
Flu symptoms vary, and some people might not show any signs of the flu. Symptoms can include a fever, chills, a cough, sore throat, runny or stuffy nose, muscle or body aches, headaches, fatigue, vomiting and diarrhea, the latter two of which can be more common in children.
Flu leads to school closures in 4 states, plus how to prepare a 'flu box'
Kids younger than 5, in particular, are at a higher risk of developing serious complications from the flu and can have the flu for a longer period of time than others.
Boler, 31, told "GMA" three of his four children, his daughters, all tested positive for influenza A at the end of February. Two of his girls have since recovered, but unlike her siblings, Locklynn's condition grew worse and she contracted pneumonia as well and collapsed at home on Feb. 24 before she was rushed to an emergency room.
"She jumps up out of the bed and runs to the bathroom. And then she collapsed right before she got to the bathroom door and it looked like she was having like, a seizure," Boler recalled, adding, "I picked her up, and then I realized that she wasn't breathing."
Boler said his fiancee and his sister did CPR and compressions on Locklynn as he drove all of them to a local hospital near their home in Chillicothe, but Locklynn was without oxygen for at least four minutes before she was successfully resuscitated.
In a matter of hours, Boler said his daughter went from being a "feisty" boss and "daddy's girl" to someone nearly unrecognizable.
"It don't feel real," he said. "It's pretty crazy. It's like, I wake up to the nightmare."
Locklynn was transferred by air ambulance on Feb. 24 to Nationwide Children's Hospital in Columbus, Ohio, where Dr. Marlina Lovett, an attending physician in the pediatric intensive care unit at Nationwide Children's, has been on her care team.
Lovett said Locklynn came into the hospital "critically ill."
"When she arrived to our hospital, she had a breathing tube in place," Lovett told "GMA." "She was on the ventilator. She was essentially unresponsive and she was very critical at that point in time."
Doctors at Nationwide Children's diagnosed Locklynn with hypoxic ischemic encephalopathy, a severe brain injury marked by myoclonus or muscle spasms.
Today, Locklynn remains on a ventilator to help her breathe and doctors expect she will have to stay in the hospital for at least the next few months.
"There are concerns about her ability to control her body with movements, how awake she'll be long-term," Lovett said. "We don't know how interactive she'll be with her parents. We suspect that she'll probably need a feeding tube all her life and she'll probably be wheelchair bound and unable to walk. But some of the other stuff, we just need more time to see what Locklynn's recovery can be."
Despite the devastating diagnosis, Boler said he and his family remain hopeful.
"She'll more likely never walk again. She'll never talk. She has no awareness. But, you know, God works in mysterious ways. You never know," Boler said. "She's little. She could always get better. We're just hopeful. We got a lot of family that are helping us, family, friends and all the prayers that we're getting."
Father warns about how serious flu can be for kids as 10-year-old son battles virus
Both Boler and Lovett said they hope that by sharing Locklynn's story, they can raise awareness about the flu and why the virus shouldn't be taken lightly.
"The flu's something we all have to take pretty seriously, because it can make kids and adults and those with additional illnesses really sick, and I think that's what we saw with Locklynn -- and unfortunately, the flu can have some very severe complications," Lovett said.
The best way to prevent or reduce the severity of flu, according to the CDC, is to get a flu vaccine. Other ways to avoid getting sick include regular handwashing, avoiding others who are sick, and covering coughs and sneezes.
"If one person sees what I'm talking about and is like, 'Look at their kid,' and like, 'Maybe we need to go to the doctor,' and it saves that kid's life, then I feel like I have [an] obligation to do that," said Boler. "I don't want this to take anybody else's babies."
Dad speaks out after 4-year-old daughter gets serious complications from flu originally appeared on goodmorningamerica.com

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Domino's Pizza, McDonald's rating surprise tied to persistent consumer issue
Domino's Pizza, McDonald's rating surprise tied to persistent consumer issue

Miami Herald

time7 hours ago

  • Miami Herald

Domino's Pizza, McDonald's rating surprise tied to persistent consumer issue

Even the Hamburglar didn't see this one coming. Excessive weight has been a persistent problem in America, where at least one in five adults in each U.S. state is living with obesity, according to the Centers for Disease Control and Prevention. Don't miss the move: Subscribe to TheStreet's free daily newsletter As obesity rates have risen, so have scientists' efforts to address this serious health issue, which can cause asthma, heart disease, stroke, type 2 diabetes and even some cancers. Early attempts to treat obesity came to the market as early as the 1930s. Amphetamines were the prevalent treatment in the 1940s and 1950s and demand continued into the 1990s. Glucagon-like peptide-1 agonists, which mimic the action of the naturally occurring hormone GLP-1, have been available for about two decades. GLP-1 medications, including Ozempic, Wegovy, Zepbound and Mounjaro, have been used for years to treat Type 2 diabetes, and studies have found that they are also effective at encouraging weight loss. Wegovy and Ozempic are manufactured by Novo Nordisk (NVO) , while Eli Lilly (LLY) makes Zepbound and Mounjaro. Image source:One investment firm says increased use of these medications could have serious implications for two of the biggest names in the fast-food industry: McDonald's (MCD) and Domino's Pizza (DPZ) . The market for anti-obesity drugs, particularly those using injectable versions of GLP 1-based drugs, is still new and continuously evolving, Goldman Sachs said in a May 22 report. More Restaurants Beloved Mexican restaurant closing iconic location after 63 yearsMajor restaurant chain quietly closes several locationsIconic restaurant closing its doors after 32 years The investment firm lowered its projections for such medication and now forecasts the global market to reach $95 billion by 2030. That's down from the previous estimate of $130 billion to reflect trends influencing how the drugs are priced, how long patients stay on them, and how patient populations are segmented. Goldman lowered its U.S. market projections to a peak of $70 billion, but the firm sees room for greater penetration in markets outside the U.S. Goldman forecasts a market peak of $50 billion outside the US, compared with $35 billion previously. A survey of more than 50 doctors in the US found that lower doses of anti-obesity medications are working well for a majority of patients and insurance coverage is the most important factor in the decision-making process, Goldman Sachs wrote. "But to be clear, even with this moderated forecast, we see a significant growth opportunity for both existing players as well as new entrants into this market," said Asad Haider, head of the health-care business unit within Goldman Sachs Research. Demand for GPL-1 drugs could dramatically hinder the food and restaurant industries, according to a study from Cornell's SC Johnson College of Business and the data firm Numerator. The report, entitled "The No Hunger Games," found that households with at least one user of GLP-1 drugs reduced its grocery spending by about 6% within six months of starting the drugs. The spending cut was as much as 9% for higher-income households. "We also find an 8.6% decline in spending at fast-food chains, coffee shops and limited-service restaurants," the study said. "Our findings highlight the potential for GLP-1 medications to significantly change food demand, a trend with increasingly important implications for the food industry as GLP-1 adoption continues to grow." The study warned that common side effects of GLP-1 medications, such as nausea, vomiting and gastrointestinal discomfort, have reportedly led to reduced adherence or discontinued use for some patients. Related: McDonald's analyst grills new stock price target on McCrispy reaction "Moreover, their long-term efficacy and safety remain areas of ongoing investigation," the report said. Redburn Atlantic analyst Chris Luyckx focused on the growing adoption of GLP-1 in recent research reports. Luyckx double-downgraded McDonald's to sell from buy with a price target of $260, down from $319. The analyst expects the GLP-1 weight-loss drugs to suppress consumer appetites and says they present an underappreciated longer-term threat for McDonald's. A 1% drag on sales today "could easily build to 10% or more over time," particularly for restaurant brands skewed toward lower-income consumers, the analyst tells investors in a research note. McDonald's stock was down about 1.3% at last check and is up 18.5% from a year ago. Redburn Atlantic also initiated coverage of Domino's Pizza with a sell rating and $340 price target. Domino's, the world's largest pizza chain, faces the heaviest pressure from adoption of GLP-1 weight loss drugs, with high exposure to dinner occasions and lower-income consumers, the firm said. Redburn Atlantic said the company's organic traffic remains weak, with carry-out far outpacing delivery. Challenged system-sales growth and elevated consensus expectations present downside risk for Domino's, the firm said. McDonald's closed regular trading on June 10 down 1.4% at $300.43. Domino's shares were off 2.7% at $455.49. Related: Fund-management veteran skips emotion in investment strategy The Arena Media Brands, LLC THESTREET is a registered trademark of TheStreet, Inc.

Former, current CDC employees call on RFK Jr. to resign
Former, current CDC employees call on RFK Jr. to resign

Axios

time9 hours ago

  • Axios

Former, current CDC employees call on RFK Jr. to resign

Current and former employees of Centers for Disease Control and Prevention are calling on Health Secretary Robert F. Kennedy Jr. to resign, warning that job cuts and proposed funding reductions will hurt the agency's ability to protect the public from future health outbreaks. Why it matters: The Atlanta-based CDC has long been the unbiased hub Americans turn to for facts about health topics, including sexually transmitted infections, maternal and infant health and respiratory infections. Driving the news: Carrying a large American flag, dozens of current employees at the facility walked out in protest of the cuts and joined people rallying in support of the department. Tuesday's protest attracted more than 100 people who packed the sidewalk along Clifton Road across from the CDC's headquarters. What they're saying: Sarah Boim, a member of Fired But Fighting, a grassroots group of former CDC employees who were terminated this year, told Axios the organization holds rallies each Tuesday in support of people who still work at the agency. "It's really hard to put into words how horrible this experience has been, not just for us, but it's going to really affect everybody in America," she said. Eric Mintz, another former CDC employee, told Axios proposed cuts to the CDC, National Institutes for Health, Food and Drug Administration and Medicaid will take away resources needed to protect people from illnesses. "It's not waste, it's not abuse, it's not fraud," Mintz said. "It's hard-working people with expertise trying to protect the American citizens." Catch up quick: The Health and Human Services Department in March announced about 2,400 positions would be eliminated from the CDC. HHS has said reducing its workforce from 82,000 to 62,000 full-time employees will cut costs from the agency's nearly $2 trillion budget. On Monday, RFK. Jr. removed all 17 members from the expert panel that makes vaccine policy recommendations to the CDC. He said in a statement the agency is "prioritizing the restoration of public trust above any specific pro- or anti-vaccine agenda." Questions are still being raised on who runs the CDC, as there is no public health official or designated point person leading the agency. State of play: Trump's fiscal year 2026 budget also recommends cutting $3.59 billion from the CDC. The budget, which was approved by the U.S. House, is still lingering in the U.S. Senate. Threat level: Anna Yousaf, an infectious diseases doctor at the CDC's National Center for Immunization and Respiratory Diseases, called Kennedy a "domestic health threat" who has dismantled programs ranging from lead poisoning prevention to maternal and infant health monitoring.

RFK Jr.‘s new attack on vaccines, briefly explained
RFK Jr.‘s new attack on vaccines, briefly explained

Vox

time10 hours ago

  • Vox

RFK Jr.‘s new attack on vaccines, briefly explained

This story appeared in The Logoff, a daily newsletter that helps you stay informed about the Trump administration without letting political news take over your life. Subscribe here. Welcome to The Logoff: Today, Dylan Scott and I are focusing on US Health Secretary Robert F. Kennedy Jr.'s decision to fire every member of a federal vaccine advisory board, an attack on medical science that will have negative repercussions for public health. What's the latest? Kennedy fired every sitting member of the Centers for Disease Control and Prevention's Advisory Committee on Immunization Practices on Monday. What does this board do? For more than 60 years, the panel has advised the federal government on vaccine policy, providing guidance — that officials have almost always followed — on which shots people should get and when. What's next? The vaccine advisory committee was first convened by the surgeon general in 1964, but it is not enshrined in federal law. That means Kennedy can change its membership or dissolve the panel entirely if he so desires. In firing the board's members, Kennedy called it 'little more than a rubber stamp for any vaccine.' What does this mean for us? Absent clear, science-based federal guidance on vaccines, it'll be harder for us to know which shots health experts think we should be getting. And, more broadly, it'll be harder for the population to achieve 'herd immunity' — when enough people are vaccinated against a disease to prevent it from spreading widely. The Logoff The email you need to stay informed about Trump — without letting the news take over your life, from senior editor Patrick Reis. Email (required) Sign Up By submitting your email, you agree to our Terms and Privacy Notice . This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply. What's the big picture? Kennedy has a long history as a vaccine 'skeptic,' promoting unfounded theories about the supposed health risks of vaccines responsible for saving millions of lives. As Health secretary, he has made vaccine policy — and undermining the value of those vaccines — a centerpiece of his agenda. And with that, it's time to log off…

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store